nitrates has been researched along with Smoking Cessation in 10 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
Smoking Cessation: Discontinuing the habit of SMOKING.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Strategies used for plaque stabilisation resulting in a reduction in cardiovascular mortality and morbidity are: smoking cessation; aspirin (acetylsalicylic acid); blood pressure control; lipid lowering agents when low density lipoprotein cholesterol is elevated despite dietary therapy; coronary bypass surgery in patients with left main stem disease or triple vessel coronary disease and diminished left ventricular function; and use of estrogen in postmenopausal women." | 4.80 | Choosing the most appropriate treatment for stable angina. Safety considerations. ( Asirvatham, S; Sebastian, C; Thadani, U, 1998) |
| "Nicotine replacement therapy appears to be safe when used by healthy patients to aid in smoking cessation; however, the immediate acute effects of nicotine replacement therapy on the circadian rhythm of blood pressure (BP) and endothelial function in heavy smokers are not well understood." | 3.73 | Blood pressure circadian rhythm and endothelial function in heavy smokers: acute effects of transdermal nicotine. ( Coelho, OR; Consolin Colombo, FM; Ferreira-Melo, SE; Irigoyen, MC; Moreno, H; Nogueira, EA; Sabha, M; Yugar-Toledo, JC, 2005) |
| "This paper concerns the medical treatment of heart failure according to the recommendations of the European Society of Cardiology." | 2.44 | [Medical treatment of chronic heart failure]. ( Schüpfer, CA, 2007) |
| "Exhaled NO levels in COPD patients were significantly higher than those of normal subjects when comparing either the total groups (9." | 1.34 | Nitric oxide and exhaled breath nitrite/nitrates in chronic obstructive pulmonary disease patients. ( Liu, J; Sandrini, A; Thomas, PS; Thurston, MC; Yates, DH, 2007) |
| "Treatment with aspirin, beta blockers, and angiotensin converting enzyme inhibitors." | 1.30 | Secondary prevention in coronary heart disease: baseline survey of provision in general practice. ( Campbell, NC; Deans, HG; Rawles, JM; Ritchie, LD; Thain, J, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamashina, Y | 1 |
| Yagi, T | 1 |
| Namekawa, A | 1 |
| Ishida, A | 1 |
| Mibiki, Y | 1 |
| Sato, H | 1 |
| Nakagawa, T | 1 |
| Sakuramoto, M | 1 |
| Sato, E | 1 |
| Komatsu, J | 1 |
| Valgimigli, M | 1 |
| Biscaglia, S | 1 |
| Campagna, D | 1 |
| Cibella, F | 1 |
| Caponnetto, P | 1 |
| Amaradio, MD | 1 |
| Caruso, M | 1 |
| Morjaria, JB | 1 |
| Malerba, M | 1 |
| Polosa, R | 1 |
| Yugar-Toledo, JC | 1 |
| Ferreira-Melo, SE | 1 |
| Sabha, M | 1 |
| Nogueira, EA | 1 |
| Coelho, OR | 1 |
| Consolin Colombo, FM | 1 |
| Irigoyen, MC | 1 |
| Moreno, H | 1 |
| Schüpfer, CA | 1 |
| Liu, J | 1 |
| Sandrini, A | 1 |
| Thurston, MC | 1 |
| Yates, DH | 1 |
| Thomas, PS | 1 |
| Campbell, NC | 1 |
| Thain, J | 1 |
| Deans, HG | 1 |
| Ritchie, LD | 1 |
| Rawles, JM | 1 |
| Asirvatham, S | 1 |
| Sebastian, C | 1 |
| Thadani, U | 1 |
| Cleland, JG | 1 |
| John, J | 1 |
| Dhawan, J | 1 |
| Clark, A | 1 |
| Thomas, S | 1 |
| Bruce, C | 1 |
| Birkhead, A | 1 |
| Wang, L | 1 |
4 reviews available for nitrates and Smoking Cessation
| Article | Year |
|---|---|
Stable angina pectoris.
Topics: Acetanilides; Angina, Stable; Benzazepines; Coronary Artery Bypass; Coronary Artery Disease; Coronar | 2014 |
[Medical treatment of chronic heart failure].
Topics: Adrenergic beta-Antagonists; Alcohol Drinking; Angiotensin-Converting Enzyme Inhibitors; Calcium Cha | 2007 |
Choosing the most appropriate treatment for stable angina. Safety considerations.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspiri | 1998 |
What is the optimal medical management of ischaemic heart failure?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Car | 2001 |
1 trial available for nitrates and Smoking Cessation
| Article | Year |
|---|---|
Changes in breathomics from a 1-year randomized smoking cessation trial of electronic cigarettes.
Topics: Adolescent; Adult; Aged; Breath Tests; Carbon Monoxide; Electronic Nicotine Delivery Systems; Exhala | 2016 |
5 other studies available for nitrates and Smoking Cessation
| Article | Year |
|---|---|
Favorable outcomes of patients with vasospastic angina associated with cardiac arrest.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Defibrillators, Implantable; Female; Follow- | 2014 |
Blood pressure circadian rhythm and endothelial function in heavy smokers: acute effects of transdermal nicotine.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Brachial Artery; Circadian Rhythm; Dose-Response R | 2005 |
Nitric oxide and exhaled breath nitrite/nitrates in chronic obstructive pulmonary disease patients.
Topics: Administration, Inhalation; Aged; Breath Tests; Glucocorticoids; Humans; Middle Aged; Nitrates; Nitr | 2007 |
Secondary prevention in coronary heart disease: baseline survey of provision in general practice.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood P | 1998 |
Effect of ecNOS polymorphisms and coronary artery disease upon exhaled nitric oxide.
Topics: Administration, Oral; Aged; Alleles; Asthma; Coronary Artery Disease; Exons; Female; Humans; Male; M | 2002 |